Press "Enter" to skip to content

Pfizer, BioNTech launch first COVID-19 vaccine trial for pregnant women

THE DAILY REFORMER (NEW YORK, UNITED STATES)

(5 NEWS ONLINE) – Drugmaker Pfizer and German partner BioNTech have begun a nine-country study of the safety and effectiveness of their COVID-19 vaccine in pregnant women.

The companies said Thursday that the first volunteers have received shots in the study, which is to enroll about 4,000 healthy pregnant women aged 18 and older. Women in the United States, Canada, Argentina, Brazil, Chile, Mozambique, South Africa, Spain and the UK will be included.

The Daily Reformer  15 House Republicans Push Georgia to Avoid ‘Disaster’ in Senate Runoffs

Dr. William Gruber, Pfizer’s head of vaccine clinical research and development, said in a statement that “pregnant women have an increased risk of complications and developing severe COVID-19,” and “it is critical that we develop a vaccine that is safe and effective” for them.

The Daily Reformer  Trump planning to raise $2 billion for a presidential library, likely in Florida: report

Read the full story ›

The post Pfizer, BioNTech launch first COVID-19 vaccine trial for pregnant women appeared first on WND.

As reported by WND. Continue reading this article at WND

The Daily Reformer  French resort opens single ski run, but you’ll need a car to reach the top

All news text, graphics, videos and multimedia content remain the copyrights of the credited original article publisher, in this case - WND

The Daily Reformer is an American conservative news aggregator and publisher with a mission to provide "the smart take on American conservative news.

Contact Information: amnon (at) thedailyreformer dot com